Skip to main content

Table 1 Results of meta-analysis (after including sensitivity analysis and subgroup analysis)

From: Association between insulin resistance, metabolic syndrome and its components and lung cancer: a systematic review and meta-analysis

Factors

Datasets

RR (95% CI)

P

I2 (%)

P of I2

Model

P of Begg’s test

MetS

6

0.99(0.90–1.09)

0.801

10.4

0.349

F

0.060

BMI

4

0.66(0.54–0.81)

0.000

0.0

0.750

F

0.308

HDL-C

5

0.73(0.54–0.99)

0.041

83.4

0.000

R

–

HDL-Ca

4

0.88(0.79–0.97)

0.010

22.3

0.277

F

0734

TG

6

0.99(0.88–1.12)

0.884

29.4

0.215

F

0.452

TC

12

0.93(0.81–1.06)

0.274

78.2

0.000

R

0.732

Both sex

3

0.77(0.50–1.19)

0.246

79.6

0.007

R

–

Men

6

0.99(0.84–1.15)

0.852

78.2

0.000

R

–

Women

3

0.98(0.80–1.19)

0.827

24.2

0.267

R

–

LDL-C

4

1.01(0.87–1.16)

0.928

45.5

0.139

F

0.734

Hypertension

6

1.01(0.88–1.15)

0.928

0.0

0.794

F

1.000

FBG

5

1.02(0.92–1.13)

0.677

16.1

0.312

F

0.462

DM

21

1.11(1.06–1.16)

0.000

34.1

0.064

F

0.833

Obesity

5

1.11(0.92–1.35)

0.280

0.0

0.445

F

0.462

IR

4

2.35(1.55–3.58)

0.000

0.0

0.426

F

0.308

  1. MetS: metabolic syndrome, FBG: fasting blood glucose, TG: triglyceride, TC: total cholesterol, HDL-C: high-density lipid-cholesterol, LDL-C: low-density lipoprotein cholesterol, BMI: body mass index, DM: diabetes mellitus, IR: insulin resistance, F: Fixed effects model, R: Random effects model
  2. aBy sensitivity analysis